2 citations,
March 2009 in “Hair transplant forum international” Hair loss at the site where hair was taken for a transplant can be due to the normal hair growth cycle.
1 citations,
February 2013 High ferritin levels might be linked to chronic hair loss.
November 2006 in “Yafteh” January 2012 in “Surgery” January 2019 in “Journal of Drug Delivery and Therapeutics” Changing six essential health practices can help prevent excessive hair shedding.
56 citations,
January 2019 in “Skin appendage disorders” The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.
19 citations,
January 2015 in “Journal of Clinical and Diagnostic Research” The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.
13 citations,
April 2018 in “Journal of The American Academy of Dermatology” People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.
3 citations,
January 2016 in “Skin appendage disorders” Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.
3 citations,
September 1994 in “Indian Journal of Dermatology, Venereology and Leprology” Hair loss in women was often caused by stress, illness, childbirth, or low hemoglobin, with most cases being telogen effluvium.
2 citations,
March 2021 in “Dermatologic Therapy” Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.
2 citations,
January 1980 in “Archives of Dermatology” The author suggests changing "telogen effluvium" to "telogen defluxion" for hair loss terminology.
1 citations,
January 2022 in “Dermatology Reports” Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.
1 citations,
January 2021 in “Turkish Journal of Medical Sciences” Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.
November 2024 in “Skin Appendage Disorders” Telogen effluvium most affects quality of life in alopecia patients.
Blood cell counts could help predict and treat alopecia areata and telogen effluvium.
June 2024 in “Al- Anbar Medical Journal” Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.
April 2024 in “Clinical dermatology review (Print)” Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
September 2023 in “Brazilian Journal of Health Review” COVID-19 may cause a common type of hair loss called telogen effluvium.
October 2022 in “Research, Society and Development” Vitamins and minerals don't significantly affect hair loss treatment in patients with telogen effluvium.
July 2022 in “المجلة العراقية للصيدلة” Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.
COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.
April 2022 in “Jurnal Ilmiah Kesehatan Media Husada” Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.
April 2021 in “International journal of advanced research” COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.
January 2020 in “Hair therapy & transplantation” Telogen effluvium is a common hair loss where hair sheds due to stress but new hair still grows.
September 2019 in “Journal of Investigative Dermatology” Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.
September 2019 in “Journal of Investigative Dermatology” Sandalore® reduces hair shedding and increases hair volume in women with telogen effluvium.
July 2018 in “Elsevier eBooks” The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.
Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.